Kurt Christensen

Kurt Christensen is an Assistant Professor of Population Medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School whose research focuses on the medical, behavioral, and economic impact of integrating genetics into clinical care for healthy patients. His work on genetic risk assessments for Alzheimer’s disease as part of the REVEAL Study provided some of the earliest evidence about the unanticipated benefits of disclosing secondary genomic findings. His current work examines the benefits, harms, and costs of population genetic screening using simulation modeling (e.g., the PreEMPT Model), observational studies (the Imagenetics METRICS Study), and randomized trials (e.g., the BabySeq Project).